Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

overall survival

  • You have access
    Prognostic Value of Peritoneal Cancer Index After Complete Cytoreductive Surgery in Advanced Ovarian Cancer
    MIHAELA ASP, SUSANNE MALANDER, JOHAN BENGTSSON, HANNA SARTOR and PAIVI KANNISTO
    Anticancer Research May 2022, 42 (5) 2541-2551; DOI: https://doi.org/10.21873/anticanres.15732
  • You have access
    Diversified Effects of Bile Contamination, Postoperative Infections, and Antimicrobial Resistance Level on the Oncologic Prognosis After Pancreatoduodenectomy for Ductal Adenocarcinoma
    LUCA GIANOTTI, KIM C. HONSELMANN, MARCO ANGRISANI, FRANCESCA GAVAZZI, TOBIAS KECK, ULRICH WELLNER, LOUISA BOLM, NATALIE PETRUCH, GIOVANNI CAPRETTI, GENNARO NAPPO, DAVIDE P. BERNASCONI, MARTA SANDINI and ALESSANDRO ZERBI
    Anticancer Research May 2022, 42 (5) 2743-2752; DOI: https://doi.org/10.21873/anticanres.15753
  • You have access
    Baseline Modified Glasgow Prognostic Score (mGPS) Predicts Radiologic Response and Overall Survival in Metastatic Hormone-sensitive Prostate Cancer Treated With Docetaxel Chemotherapy
    MANUEL NEUBERGER, JANINA SKLADNY, NORA GOLY, FREDERIK WESSELS, CHRISTEL WEIß, LUISA EGEN, PHILIPP ERBEN, MATTHIAS GROß-WEEGE, BRITTA GRÜNE, FRIEDRICH HARTUNG, JONAS HERRMANN, PATRICK HONECK, JONAS JARCZYK, KARL-FRIEDRICH KOWALEWSKI, JULIA MÜHLBAUER, KATJA NITSCHKE, MALIN NIENTIEDT, MARGARETE THERESA WALACH, FRANK WALDBILLIG, NIKLAS WESTHOFF, JOST VON HARDENBERG, MAXIMILIAN KRIEGMAIR, THOMAS S. WORST and PHILIPP NUHN
    Anticancer Research April 2022, 42 (4) 1911-1918; DOI: https://doi.org/10.21873/anticanres.15668
  • You have access
    Can Previous Chemotherapy Affect the Outcome of Nivolumab Treatment in Non-small Cell Lung Cancer?
    MARTIN SVATON, MONIKA BRATOVA, LEONA KOUBKOVA, ONDREJ FISCHER, BOHUSLAV MELICHAR, MICHAL HRNCIARIK, DANIEL DOLEZAL, ONDREJ BILEK, JANA KREJCI, MARIE DROSSLEROVA, ZDENKA DLOUHA, JIRI BLAZEK, PETRA MAJKOVA, LUCIE BROZOVA and MAREK STASTNY
    Anticancer Research April 2022, 42 (4) 1987-1995; DOI: https://doi.org/10.21873/anticanres.15677
  • Open Access
    Efficacy of New Therapies for Relapse After Docetaxel Treatment of Bone Metastatic Castration-resistant Prostate Cancer in Clinical Practice
    ATSUSHI MIZOKAMI, KOSHIRO NISHIMOTO, HIDEYASU MATSUYAMA, TOMOHIKO ICHIKAWA, SATORU TAKAHASHI, HIROAKI SHIINA, KATSUYOSHI HASHINE, YUTAKA SUGIYAMA, MANABU KAMIYAMA, HIDEKI ENOKIDA and KENICHI NAKAJIMA
    Anticancer Research March 2022, 42 (3) 1465-1475; DOI: https://doi.org/10.21873/anticanres.15617
  • You have access
    Correlation Between Clinical Outcomes and Serum CA-125 Levels After Standard Treatment for Epithelial Ovarian Cancer
    JUHUN LEE, JONG MI KIM, YOON HEE LEE, GUN OH CHONG and DAE GY HONG
    Anticancer Research January 2022, 42 (1) 349-353; DOI: https://doi.org/10.21873/anticanres.15492
  • You have access
    Effects of Circulating 25(OH)D Status in Advanced Colorectal Cancer Patients Undergoing Chemotherapy: A Systematic Review
    XIAOFENG ZENG, LIYING ZHANG, SHULI JIA, TAIPING LIN, GONGXIANG LIU, JIRONG YUE and XIAOLI HUANG
    Anticancer Research December 2021, 41 (12) 5903-5912; DOI: https://doi.org/10.21873/anticanres.15409
  • You have access
    Survival Response of Patients With Gastric Cancer Treated With Regional Arterial-Perfusion Chemotherapy Is Correlated With Borrmann Classification
    YE MA, XIANXIAN LIANG, LI LIU, DAZHI GAO, TAO YANG, ROBERT M. HOFFMAN and JIAN XU
    Anticancer Research November 2021, 41 (11) 5507-5515; DOI: https://doi.org/10.21873/anticanres.15364
  • You have access
    Frailty Can Predict Prognosis After Hepatectomy in Patients With Colorectal Liver Metastasis
    KAZUNORI TOKUDA, YUJI MORINE, KATSUKI MIYAZAKI, SHINICHIRO YAMADA, YU SAITO, MASAAKI NISHI, TETSUYA IKEMOTO and MITSUO SHIMADA
    Anticancer Research September 2021, 41 (9) 4637-4644; DOI: https://doi.org/10.21873/anticanres.15277
  • You have access
    Risk–benefit Analysis of FOLFIRI Plus Ramucirumab/Aflibercept as a Third-line Treatment in Metastatic Colorectal Cancer
    MICHIO KIMURA, EISEKI USAMI, HITOMI TERAMACHI and TOMOAKI YOSHIMURA
    Anticancer Research June 2021, 41 (6) 3091-3097; DOI: https://doi.org/10.21873/anticanres.15093

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 11
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire